the value and strategy for incorporating biosimilars into clinical practice
Published 7 years ago • 34 plays • Length 4:53Download video MP4
Download video MP3
Similar videos
-
16:22
incorporating ibd biosimilars into practice: patient care and education
-
53:18
utilization of biosimilars: achieving value-based plan management
-
16:47
what is needed and what is the role of biosimilars?
-
14:19
regulatory pathway for biosimilars
-
59:48
generic drugs and biosimilars 101
-
3:33
biosimilars: manufacturing and inherent variation
-
6:35
how biosimilar medicines will replace generic medicines in the future!!!
-
6:43
biosimilars
-
5:29
the science of biosimilarity: immunogenicity
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
53:46
biosimilars - impact for patients
-
5:20
data requirements for biosimilars
-
2:04
biosimilars: the path to approval
-
40:51
biologics and biosimilars interchangeability: a deep dive with industry experts
-
39:48
optimizing biosimilars for safe and effective management of imids
-
38:15
biosimilars and biologics
-
50:28
biosimilars and the oncology pcsp: value-based strategies to improve access and reduce cost
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
2:57
effective communication about biosimilars
-
2:38
clinical trials in the development of biosimilars – video abstract [id 59825]
-
3:45
what are biosimilars? how do they work for arthritis?
-
0:51
fast facts about extrapolation for biosimilars - amgen science